German team elaborates on how to reduce PET/MRI scan times April 21, 2023 -- PET/MRI breast cancer imaging time can be cut in half without losing key diagnostic information, and this could increase the use of the modality for this indication and streamline patient throughput, investigators from the University of Dusseldorf have found.Read More
PET/CT proves superior in detecting invasive breast cancer April 17, 2023 -- PET/CT imaging surpasses bone scintigraphy for detecting bone metastases in women with invasive breast cancer and should be the technique of choice to stage these patients, according to a team of investigators from Portugal.Read More
SPECT/CT helps assess patients with knee pain following arthroplasty April 6, 2023 -- SPECT/CT is an effective way to evaluate noninfected painful knees in patients after they have undergone arthroplasty, according to new global research. The technique proved particularly accurate in cases of joint loosening, patellofemoral disorders, and component malalignment.Read More
Ablaze announces progress on liver cancer therapy April 3, 2023 -- Ablaze Pharmaceuticals has licensed a peptide drug candidate from RayzeBio that it will develop to target the liver cancer biomarker GPC3. The plans is to market the new drug in China, where the company is headquartered.Read More
Hybrid PET/CT scanners: An imaging revolution or more hype? March 15, 2023 -- Total-body and long axial field-of-view PET/CT scanners have the potential to dramatically improve imaging in patients, but can they be considered a revolution in the field? That question was debated during a discussion at ECR 2023 in Vienna.Read More
Will lecanemab approval increase PET scan volumes? March 13, 2023 -- Europe could see increased demand for PET imaging if the monoclonal antibody lecanemab receives regulatory approval for the treatment of Alzheimer's disease, the European Association for Nuclear Medicine has stated.Read More
GE HealthCare focuses on upgrades and 'experiences' at ECR 2023 March 5, 2023 -- VIENNA - At ECR 2023, GE HealthCare showcased a range of new imaging hardware and software, as well as "immersive experiences." For the first time, it participated in an ECR as an independent public traded company.Read More